The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

Vertex Pharmaceuticals Inc

Nasdaq: VRTX
Last

(U.S.) $136.76

Today's change+1.93 +1.43%
Updated June 22 12:44 PM EDT. Delayed by at least 15 minutes.
 

Vertex Pharmaceuticals Inc

Nasdaq: VRTX
Last

(U.S.) $136.76

Today's change+1.93 +1.43%
Updated June 22 12:44 PM EDT. Delayed by at least 15 minutes.

Vertex Pharmaceuticals Inc Hits New 100-day High

Vertex Pharmaceuticals Inc is up today by (U.S.)$1.93 or 1.43% to (U.S.)$136.76 and setting a new 100-day high. Over the last five days, shares have gained 10.25% and 85.64% year to date. Shares have outperformed the S&P 500 by 43.49% during the last year.

Key company metrics

  • Open(U.S.) $134.65
  • Previous close(U.S.) $134.83
  • High(U.S.) $136.79
  • Low(U.S.) $132.76
  • Bid / Ask(U.S.) $136.63 / (U.S.) $136.78
  • YTD % change+85.64%
  • Volume1,158,008
  • Average volume (10-day)1,954,989
  • Average volume (1-month)1,845,835
  • Average volume (3-month)1,899,378
  • 52-week range(U.S.) $71.46 to (U.S.) $136.79
  • Beta1.75
  • Trailing P/E193.14×
  • P/E 1 year forward81.26×
  • Forward PEG1.32×
  • Indicated annual dividend--
  • Dividend yield0.00%
  • Trailing EPS(U.S.) $0.71
Updated June 22 12:44 PM EDT. Delayed by at least 15 minutes.

Latest Company News

View more News

Latest Press Releases

View more Press Releases
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q1/2017Q4/2016Q3/2016Q2/2016
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedMar 31, 201703/31/2017Dec 31, 201612/31/2016Sep 30, 201609/30/2016Jun 30, 201606/30/2016
Revenue715459414432
Total other revenue--------
Total revenue715459414432
Gross profit668399361387
Total cost of revenue46605344
Total operating expense444419433428
Selling / general / administrative113110106112
Research & development274248272271
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)10000
Other operating expenses, total1111
Operating income27140-193
Interest income (expense), net non-operating-17------
Gain (loss) on sale of assets--------
Other--------
Income before tax25420-39-18
Income after tax25028-40-36
Income tax, total4-7118
Net income24833-39-65
Total adjustments to net income--------
Net income before extra. items24833-39-65
Minority interest-251-28
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items24833-39-65
Inc. avail. to common incl. extra. items24833-39-65
Diluted net income24833-39-65
Dilution adjustment--------
Diluted weighted average shares249245245244
Diluted EPS excluding extraordinary itemsvalue per share1.000.13-0.16-0.26
Dividends per sharevalue per share0.000.000.000.00
Diluted normalized EPSvalue per share1.040.13-0.16-0.26